Circadin Prolonged Release Tablets contain the active ingredient melatonin, and are used to treat individuals aged ≥55 years who experience primary insomnia. This condition is characterised by poor quality sleep. Circadin is used to improve sleep quality and morning alertness on a short term basis (for up to three weeks).

For more information, see Circadin Prolonged Release Tablets.

All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.